You are here

Article info

Article menu

other Versions

Download PDFPDF
Original research
Anlotinib in recurrent or metastatic endometrial cancer

Authors

  • Qingli Cui Department of Integrated Traditional Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Yuefeng Mao Department of Medical Oncology, Second People's Hospital of Pingdingshan, Pingdingshan, Henan, China PubMed articlesGoogle scholar articles
  • Yanhui Hu Department of Integrated Traditional Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Dongyang Ma Department of Integrated Traditional Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Huaimin Liu Department of Integrated Traditional Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Huaimin Liu, Department of Integrated Traditional Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450003, China; huaiminliu{at}sina.com
View Full Text

Citation

Cui Q, Mao Y, Hu Y, et al
Anlotinib in recurrent or metastatic endometrial cancer
International Journal of Gynecologic Cancer Published Online First: 23 May 2022. doi: 10.1136/ijgc-2022-003345

Publication history

  • Received January 2, 2022
  • Accepted April 26, 2022
  • First published May 23, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.